Full Text View
Tabular View
No Study Results Posted
Related Studies
A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma
This study has been terminated.
( slow accrual and financial resource limitation )
Study NCT00476554   Information provided by Cyclacel Pharmaceuticals, Inc.

First Received on May 19, 2007.   Last Updated on November 7, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial